Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引：0
|
作者：
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3507 / 3512
页数：5
相关论文
共 50 条
  • [21] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
    Sol Cortés de Miguel
    Miguel Ángel Calleja-Hernández
    Salomón Menjón-Beltrán
    Inmaculada Vallejo-Rodríguez
    Supportive Care in Cancer, 2015, 23 : 547 - 559
  • [22] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    S Kelly
    D Wheatley
    British Journal of Cancer, 2009, 101 : S6 - S10
  • [23] The role of granulocyte colony-stimulating factor in breast cancer development: A review
    Liu, Li
    Liu, Yangyang
    Yan, Xiaohua
    Zhou, Chong
    Xiong, Xiangyang
    MOLECULAR MEDICINE REPORTS, 2020, 21 (05) : 2019 - 2029
  • [24] Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
    Ahuva Averin
    Amanda Silvia
    Lois Lamerato
    Kathryn Richert-Boe
    Manpreet Kaur
    Devi Sundaresan
    Neel Shah
    Mark Hatfield
    Tatiana Lawrence
    Gary H. Lyman
    Derek Weycker
    Supportive Care in Cancer, 2021, 29 : 2179 - 2186
  • [25] Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia
    Se-Il Go
    Eun-Jeong Jeong
    Woo Je Lee
    Sungwoo Park
    Mi Jung Park
    Gyeong-Won Lee
    Supportive Care in Cancer, 2025, 33 (7)
  • [26] Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, Hongki
    Park, Seon Young
    Shin, Juhee
    Han, Hye Sug
    Suh, Young Jin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (02) : 59 - 66
  • [27] Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 & 12 in Breast Cancer Patients: A Retrospective Analysis
    Yerushalmi, Rinat
    Goldvaser, Hadar
    Sulkes, Aaron
    Ben-Aharon, Irit
    Hendler, Daniel
    Neiman, Victoria
    Ciuraru, Noa Beatrice
    Bonilla, Luisa
    Amit, Limor
    Zer, Alona
    Granot, Tal
    Rizel, Shulamith
    Stemmer, Salomon M.
    PLOS ONE, 2014, 9 (10):
  • [28] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Skedgel, Chris
    Rayson, Daniel
    Younis, Tallal
    SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 387 - 394
  • [29] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Chris Skedgel
    Daniel Rayson
    Tallal Younis
    Supportive Care in Cancer, 2016, 24 : 387 - 394
  • [30] The prophylactic effects of long-acting granulocyte colony-stimulating factor for febrile neutropenia in newly diagnosed patients with epithelial ovarian cancer: a randomised controlled study
    Li, Lei
    Ma, Shuiqing
    Wu, Ming
    Tan, Xianjie
    Zhong, Sen
    Lang, Jinghe
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2019, 9 (04) : 373 - 380
12345